| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.71M | 18.54M | 12.66M | 19.03M | 18.16M | 13.66M |
| Gross Profit | 5.60M | 5.31M | 2.78M | 4.15M | 3.97M | 2.74M |
| EBITDA | -978.35K | -2.02M | -3.24M | -1.77M | -1.86M | -1.57M |
| Net Income | -559.22K | -1.37M | -2.82M | -1.32M | -3.12M | -1.80M |
Balance Sheet | ||||||
| Total Assets | 40.27M | 41.28M | 42.84M | 48.19M | 50.98M | 51.72M |
| Cash, Cash Equivalents and Short-Term Investments | 30.73M | 32.20M | 33.28M | 25.86M | 42.23M | 41.98M |
| Total Debt | 85.75K | 237.79K | 584.36K | 819.47K | 1.08M | 1.31M |
| Total Liabilities | 1.65M | 1.94M | 1.87M | 3.14M | 3.18M | 2.25M |
| Stockholders Equity | 38.62M | 39.35M | 40.97M | 45.06M | 47.80M | 49.47M |
Cash Flow | ||||||
| Free Cash Flow | -162.69K | 236.11K | -1.31M | -5.17M | 94.09K | -21.37K |
| Operating Cash Flow | 458.34K | 1.10M | 316.99K | -4.90M | 474.07K | 226.78K |
| Investing Cash Flow | 3.22M | 3.47M | 2.00M | -31.15M | 24.69M | 9.75M |
| Financing Cash Flow | -1.98M | -1.73M | -2.27M | -1.51M | 474.28K | -1.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | C$106.41M | ― | -97.92% | ― | -18.13% | 0.52% | |
| ― | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
| ― | C$962.69M | ― | -87.47% | ― | 331.08% | 15.77% | |
| ― | C$862.76M | ― | -2.58% | 2.07% | 0.44% | -434.16% | |
| ― | C$264.53M | -326.81 | -1.52% | ― | 39.78% | 72.34% | |
| ― | C$137.92M | ― | -3.15% | 3.02% | 2.58% | 92.55% | |
| ― | C$175.05M | ― | -40.55% | ― | ― | 68.75% |
EcoSynthetix Inc. has secured two new tissue line contracts in Europe for its bio-based strength aid, SurfLock™, through a partnership with RNM Group. This development highlights the growing recognition of SurfLock™’s value in strengthening paper applications while using cost-effective or recycled materials, enhancing EcoSynthetix’s market position and expanding its reach in the tissue industry.
The most recent analyst rating on (TSE:ECO) stock is a Hold with a C$4.00 price target. To see the full list of analyst forecasts on EcoSynthetix stock, see the TSE:ECO Stock Forecast page.